| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | PRICE T ROWE ASSOCIATES INC /MD/ | $47.2M | 3.0M | ▲New +3.0M sh | Q1 2026 | |
| 2 | JANUS HENDERSON GROUP PLC | $29.1M | 1.8M | ▲11× Added · +1.6M sh | Q1 2026 | |
| 3 | Venrock Adviser, LLC | $26.8M | 1.7M | ▲New +1.7M sh | Q1 2026 | |
| 4 | PERCEPTIVE ADVISORS LLC | $23.2M | 1.4M | ▲+230% Added · +1.0M sh | Q1 2026 | |
| 5 | Ikarian Capital, LLC | $16.3M | 1.0M | ▲+5.2% Added · +50K sh | Q1 2026 | |
| 6 | Logos Global Management LP | $10.0M | 625K | ▲New +625K sh | Q1 2026 | |
| 7 | MORGAN STANLEY | $9.5M | 597K | ▲~0% Added · +188 sh | Q1 2026 | |
| 8 | Velan Capital Investment Management LP | $9.3M | 583K | ▲+600% Added · +500K sh | Q1 2026 | |
| 9 | ADAGE CAPITAL PARTNERS GP, L.L.C. | $8.6M | 540K | ▲+548% Added · +457K sh | Q1 2026 | |
| 10 | Point72 Asset Management, L.P. | $8.5M | 534K | ▲+26% Added · +111K sh | Q1 2026 | |
| 11 | MILLENNIUM MANAGEMENT LLC | $8.5M | 534K | ▲+77% Added · +231K sh | Q1 2026 | |
| 12 | ARMISTICE CAPITAL, LLC | $7.7M | 479K | ▲New +479K sh | Q1 2026 | |
| 13 | Siren, L.L.C. | $6.8M | 427K | —Held | Q1 2026 | |
| 14 | TD ASSET MANAGEMENT INC | $6.4M | 399K | ▲New +399K sh | Q1 2026 | |
| 15 | UBS Group AG | $6.1M | 381K | ▲564× Added · +381K sh | Q1 2026 | |
| 16 | RTW INVESTMENTS, LP | $5.9M | 370K | ▼−2.1% Reduced · −8K sh | Q1 2026 | |
| 17 | BOOTHBAY FUND MANAGEMENT, LLC | $5.9M | 367K | ▲+4.1% Added · +15K sh | Q1 2026 | |
| 18 | MARSHALL WACE, LLP | $5.6M | 353K | ▲+18% Added · +54K sh | Q1 2026 | |
| 19 | BVF INC/IL | $5.4M | 340K | —Held | Q1 2026 | |
| 20 | GREAT POINT PARTNERS LLC | $5.2M | 327K | ▲New +327K sh | Q1 2026 | |
| 21 | Woodline Partners LP | $5.2M | 324K | ▲+126% Added · +180K sh | Q1 2026 | |
| 22 | FMR LLC | $5.2M | 323K | ▲+129% Added · +182K sh | Q1 2026 | |
| 23 | AMERIPRISE FINANCIAL INC | $4.5M | 280K | ▲New +280K sh | Q1 2026 | |
| 24 | VANGUARD CAPITAL MANAGEMENT LLC | $4.2M | 263K | ▲New +263K sh | Q1 2026 | |
| 25 | Avidity Partners Management LP | $3.5M | 216K | ▲New +216K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| Company | Co-held by | Combined value |
|---|---|---|
| TANGO THERAPEUTICS INCTNGX | 15 funds | $688.5M |
| COGENT BIOSCIENCES INCCOGT | 15 funds | $687.0M |
| OLEMA PHARMACEUTICALS INCOLMA | 15 funds | $250.8M |
| REVOLUTION MEDICINES INCRVMD | 14 funds | $1.3B |
| DEXCOM INCDXCM | 14 funds | $242.5M |
| ELI LILLY & COLLY | 13 funds | $1.4B |
| INTUITIVE SURGICAL INCISRG | 13 funds | $1.3B |
| ERASCA INCERAS | 13 funds | $970.5M |
| BOSTON SCIENTIFIC CORPBSX | 13 funds | $767.9M |
| CYTOKINETICS INCCYTK | 13 funds | $598.6M |
| ABIVAX SA-ADRABVX | 13 funds | $496.6M |
| APELLIS PHARMACEUTICALS INCAPLSUSD | 13 funds | $392.4M |
Ranked by how many of TENX's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Jul 13, 2026 | Giordano Christopher Thomas | CEO, Director | Option exercise (M) | 219 | $777 |
| Jul 13, 2026 | Giordano Christopher Thomas | CEO, Director | Option exercise (M) | 9K | $50K |
| Jul 13, 2026 | Giordano Christopher Thomas | CEO, Director | Option exercise (M) | 219 | $0 |
| Jul 13, 2026 | Giordano Christopher Thomas | CEO, Director | Option exercise (M) | 9K | $0 |
| May 11, 2026 | STAAB THOMAS R II | Chief Financial Officer | Grant (A) | 10K | $0 |
| May 11, 2026 | STAAB THOMAS R II | Chief Financial Officer | Grant (A) | 450K | $0 |
| Jan 30, 2026 | MCGAULEY THOMAS | Interim CFO | Option exercise (M) | 50K | $0 |
| Jan 9, 2026 | PROEHL GERALD T | Director | Grant (A) | 3K | $0 |
| Jan 9, 2026 | Almenoff June Sherie | Director | Grant (A) | 30K | $0 |
| Jan 9, 2026 | Davidson Michael H. | Director | Grant (A) | 30K | $0 |
| Jan 9, 2026 | Doogan Declan | Director | Grant (A) | 30K | $0 |
| Jan 9, 2026 | Hunter Robyn | Director | Grant (A) | 30K | $0 |
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/TENX/capital-change-brief"
Use Arkolith's capital_change_brief for TENX. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for TENX. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.